Get started
Author

Örjan Nordle

A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden
1982 · Bo Ursing, Thor Alm, et al. · Gastroenterology · 347
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
2005 · C. Polman, F. Barkhof, et al. · Neurology · 224
Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
2011 · Roberto Pili, Michael Häggman, et al. · Journal of Clinical Oncology · 210
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer
2018 · Andrew J. Armstrong, Aseem Anand, et al. · JAMA Oncology · 103
PDF
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer
2009 · O Bratt, M Häggman, et al. · British Journal of Cancer · 66
PDF
Release of 17-Beta-Oestradiol from a Vaginal Ring in Postmenopausal Women: Pharmacokinetic Evaluation
2010 · Günther Schmidt, Sven-Börje Andersson, et al. · Gynecologic and Obstetric Investigation · 58
Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
2013 · A.J. Armstrong, M. Häggman, et al. · Clinical Cancer Research · 55
A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma
2007 · D M Shaw, N B Connolly, et al. · British Journal of Cancer · 55
PDF
A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden
1982 · Anders Rosén, Bo Ursing, et al. · Gastroenterology · 53
Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)
2014 · Andrew J. Armstrong, Reza Kaboteh, et al. · Urologic Oncology Seminars and Original Investigations · 49
Immediate Estrogen or Estramustine Phosphate Therapy Versus Deferred Endocrine Treatment in Nonmetastatic Prostate Cancer: A Randomized Multicenter Study With 15 Years of Followup
1995 · Rolf Lundgren, Orjan Nordle, et al. · The Journal of Urology · 39
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer
1995 · J.F. Smyth, J.D. Hardcastle, et al. · Annals of Oncology · 34
PDF
A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis
2016 · Robert E. Hawkins, Martin Gore, et al. · Clinical Cancer Research · 33
A self‐adjusting randomization plan for allocation of patients into two treatment groups
1977 · Orjan Nordle, Bo Brantmark · Clinical Pharmacology & Therapeutics · 32
Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
1980 · L Andersson, T Berlin, et al. · PubMed · 28
Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α
2015 · Eyad Elkord, Deborah J. Burt, et al. · Oncotarget · 20
PDF
Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients
2008 · FELIX MITELMAN, BODIL STRÖMBECK, et al. · Hereditas · 16
Treatment of High-grade, High-stage Prostate Cancer with Estramustine Phosphate or Diethylstilbestrol: A double-blind Study
1997 · P. O. Hedlund, H. Jacobsson, et al. · Scandinavian Journal of Urology and Nephrology · 12
Tasquinimod and survival in men with metastatic castration-resistant prostate cancer: Results of long-term follow-up of a randomized phase II placebo-controlled trial.
2012 · Andrew J. Armstrong, Michael Haggman, et al. · Journal of Clinical Oncology · 10
Dissolution rate-limited absorption and complete bioavailability of roquinimex in man
1999 · Kerstin Strandgården, Peter Höglund, et al. · Biopharmaceutics & Drug Disposition · 10
Immediate Estrogen or Estramustine Phosphate Therapy Versus Deferred Endocrine Treatment in Nonmetastatic Prostate Cancer
1995 · Rolf Lundgren, Orjan Nordle, et al. · The Journal of Urology · 10
Phase II study of tasquinimod in chemotherapy-naive patients with metastatic castrate-resistant prostate cancer (CRPC): Safety and efficacy analysis including subgroups.
2011 · A. J. Armstrong, M. Haggman, et al. · Journal of Clinical Oncology · 6
Phase 3 prognostic analysis of the automated bone scan index (aBSI) in men with bone-metastatic castration-resistant prostate cancer (CRPC).
2017 · Andrew J. Armstrong, Lars Edenbrandt, et al. · Journal of Clinical Oncology · 5
A randomized phase II/III study of naptumomab estafenatox plus IFN-α versus IFN-α in advanced renal cell carcinoma.
2013 · Robert E. Hawkins, Martin Eric Gore, et al. · Journal of Clinical Oncology · 5
Tasquinimod Mechanism of Action Biomarkers: Correlation with PFS and Survival in Men with Metastatic Castrate Resistant Prostate Cancer Treated in a Randomized Phase 2 Trial
2012 · M. Carducci, A. Armstrong, et al. · Annals of Oncology · 3
PDF
Works count: 44
Citation count: 1,491
H-index: 16
I10-index: 21
Year
Topic
Type